2m 2m 2m 2m 2m 2m 2m
OMNIAB (OABI)
NASDAQ
$4.57+$0.10 (+2.13%)
Price as of Sep 21, 2026 1:48 PM EDT- $649.9MMarket Cap
- 177.64%1-Year Change
- BiotechnologyIndustry
OMNIAB (OABI)
$4.57+$0.10 (+2.13%)
OABI | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.47 | ||
Change | +$0.03 (+0.68%) | ||
Open | $4.43 | ||
High | $4.50 | ||
Low | $4.30 | ||
Previous Close | $4.44 | ||
Volume | 1,862,358 | ||
30-Day Average Volume | 1,683,077 | ||
1-Week Change | 9.83% | ||
1-Month Change | 14.03% | ||
1-Year Change | 177.64% | ||
3-Year Change | -12.52% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 145.4M | ||
Total Assets | $290.3M | ||
Market Cap | $649.9M | ||
Enterprise Value | $625.6M | ||
Period: QTR TTM FY | |||
Revenue | $9.5M | ||
Net Income | -$5.9M | ||
Free Cash Flow | $2.6M | ||
EBIT | -$6.2M | ||
EBITDA | -$3.2M | ||
Net Working Capital | $52.3M | ||
EPS | -$0.05 | ||
Enterprise Value/EBITDA | -198 | ||
Enterprise Value/Revenue | 66 | ||
P/B | 2 | ||
P/E | -89 | ||
PEG | -5 | ||
Price/Free Cash Flow | 253 | ||
Price/Operating Cash Flow | 243 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue